Elanco Animal Health INC Form 4 insider transactions

Director Art A. Garcia of Elanco Animal Health Inc. acquired shares through equity awards, increasing his beneficial ownership.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health, acquired company shares and deferred stock units on May 15, 2026.

Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., reported a transaction involving the acquisition of common stock.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health, reported a transaction involving deferred stock units.

Elanco Animal Health Inc. reports a transaction involving deferred stock units by President, CEO, and Director Jeffrey N. Simmons.

Elanco Animal Health CEO Jeffrey N. Simmons acquired 119.3805 deferred stock units as part of the company's executive compensation plan.

Elanco Animal Health CFO Robert M. VanHimbergen acquired 8.3201 deferred stock units as part of a company compensation plan.

Elanco Animal Health executive Rajeev A. Modi acquired 62.3704 deferred stock units as part of a company compensation plan.

Rajeev A. Modi, Executive Vice President at Elanco Animal Health Inc., acquired deferred stock units representing the right to receive company common stock.

Jeffrey N. Simmons, President, CEO, and Director of Elanco Animal Health Inc., reported a transaction involving deferred stock units.

Robert M. VanHimbergen, EVP and CFO of Elanco Animal Health Inc., acquired deferred stock units representing the right to receive company common stock.

Ellen de Brabander, Executive Vice President at Elanco Animal Health, reported transactions involving company common stock.

Director Kapila K. Anand acquired 600.7104 deferred stock units in Elanco Animal Health through a director fee deferral plan.

Elanco Animal Health Inc.'s President and CEO, Jeffrey N. Simmons, acquired 117.887 deferred stock units.

Elanco Animal Health Inc. Executive Vice President Rajeev A. Modi acquired 61.5901 deferred stock units, increasing his beneficial ownership to 9,072.9178 units.

Elanco Animal Health Inc.'s EVP and CFO, Robert M. VanHimbergen, acquired 8.216 deferred stock units under a pre-arranged plan.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, disposed of 4,392 shares of common stock to cover tax withholding obligations.

Elanco Animal Health Inc.'s General Counsel and Corporate Secretary, Shiv O'Neill, reported a disposition of 4,738 common shares at $24.88 each, primarily for tax liability.

Elanco Animal Health Inc.'s CEO, Jeffrey N. Simmons, disposed of 37,898 shares of common stock to cover tax liabilities at a price of $24.88 per share.

Elanco Animal Health Inc. Executive Vice President Timothy J. Bettington reported the disposition of 4,695 common shares at $24.88 per share.

An Elanco Animal Health Inc. executive disposed of 6,492 common shares to cover tax withholding obligations at a price of $24.88 per share.

Elanco Animal Health's Executive Vice President, Jose Manuel Correia de Simas, reported a disposition of 3,371 common shares for tax liability purposes.

Elanco Animal Health's Executive Vice President, Ellen de Brabander, disposed of 8,262 common shares in a pre-planned transaction for tax liability.

An Elanco Animal Health Inc. executive disposed of 3,433 shares of common stock to cover tax liabilities related to equity compensation.

Elanco Animal Health's EVP of Manufacturing and Quality, Grace McArdle, sold 4,322 shares of common stock to cover tax liabilities.

Elanco Animal Health's Chief Accounting Officer, James M. Meer, disposed of 1,389 shares of common stock to cover tax withholding obligations.

Elanco Animal Health's Chief Accounting Officer, James M. Meer, reported the acquisition of common stock and restricted stock units, increasing his beneficial ownership.

Elanco Animal Health's Executive Vice President, Rajeev A. Modi, reported significant acquisitions of common stock, restricted stock units, stock options, and deferred stock units.

Elanco Animal Health Inc. Executive Vice President Ramiro Martin Cabral reported significant equity grants and a tax-related disposition of common stock.

Elanco Animal Health Inc's EVP of Manufacturing and Quality, Grace McArdle, reported significant equity grants and option awards, alongside a disposition for tax purposes.